N4 Pharma (N4P.L): Formulation update | Beximco Pharma (BXP.L): Appointment of Non-Executive Directors | Tekcapital PLC (TEK.LN): Belluscura Files 510(k) for XPLO2R™ Portable Oxygen Concentrator

03 Dec 2020
SP Angel Healthcare Conditions

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
N4 Pharma Plc (N4P:LON), 0.5 | Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON), 36.0 | Tekcapital Plc (TEK:LON), 7.0
- Published:
03 Dec 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3 -
N4 Pharma (N4P.L): Formulation update | Beximco Pharma (BXP.L): Appointment of Non-Executive Directors | Tekcapital PLC (TEK.LN): Belluscura Files 510(k) for XPLO2R™ Portable Oxygen Concentrator